Johnson & Johnson (JNJ) Stock Value Rose While Northstar Asset Management Cut Its Position; Sirios Capital Management LP Trimmed Holding in Consolidated Comm Hldgs (CNSL) by $670,397

Johnson & Johnson (NYSE:JNJ) Logo

Northstar Asset Management Llc decreased its stake in Johnson & Johnson (JNJ) by 8.71% based on its latest 2018Q3 regulatory filing with the SEC. Northstar Asset Management Llc sold 3,695 shares as the company’s stock rose 5.87% while stock markets declined. The institutional investor held 38,747 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $5.35M, down from 42,442 at the end of the previous reported quarter. Northstar Asset Management Llc who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $359.27B market cap company. The stock decreased 9.39% or $13.88 during the last trading session, reaching $133.96. About 43.38M shares traded or 497.57% up from the average. Johnson & Johnson (NYSE:JNJ) has risen 3.75% since December 14, 2017 and is uptrending. It has outperformed by 3.75% the S&P500. Some Historical JNJ News: 17/04/2018 – J&J – EXPECTS ACTIONS TO GENERATE APPROXIMATELY $0.6 TO $0.8 BLN IN ANNUAL PRE-TAX COST SAVINGS THAT WILL BE SUBSTANTIALLY DELIVERED BY 2022; 05/04/2018 – Johnson & Johnson Institute Adds Innovative Analytics-Based Learning Platform to Help Surgeons Improve Technical Skills and Clinical Outcomes Across a Range of Specialties; 26/04/2018 – J&J – DECLARED A 7.1% INCREASE IN QUARTERLY DIVIDEND RATE, FROM $0.84 PER SHARE TO $0.90 PER SHARE; 17/04/2018 – J&J SEES PRETAX RESTRUCTURING CHARGES $1.9B-$2.3B; 02/04/2018 – J J EXPORTERS LTD JJEX.BO SAYS CO APPROVES SALE OF PLANT, MACHINERY OF BHAGALPUR UNIT; 27/03/2018 – FDA: Johnson & Johnson Consumer, Inc.- Johnson & Johnson BAND-AID® Brand First Aid Products HURT-FREE® Wrap (size: 2in); 26/04/2018 – J&J REPORTS DIV BOOST OF 7.1% TO 90C/SHR, EST. 88C; 06/03/2018 – Boehringer Ingelheim and Lilly expand heart failure program for Jardiance® with new exercise capacity trials; 24/05/2018 – NICTUS HOLDINGS SAYS JJ RETIEF RESIGNS AS DIRECTOR; 11/05/2018 – Natrecor (Nesiritide; Johnson & Johnson) Drug Outlook to 2025 – ResearchAndMarkets.com

Sirios Capital Management LP decreased its stake in Consolidated Comm Hldgs Inc (CNSL) by 11.25% based on its latest 2018Q3 regulatory filing with the SEC. Sirios Capital Management LP sold 51,569 shares as the company’s stock declined 7.65% with the market. The hedge fund held 406,945 shares of the public utilities company at the end of 2018Q3, valued at $5.31M, down from 458,514 at the end of the previous reported quarter. Sirios Capital Management LP who had been investing in Consolidated Comm Hldgs Inc for a number of months, seems to be less bullish one the $802.28 million market cap company. The stock increased 0.72% or $0.08 during the last trading session, reaching $11.26. About 259,173 shares traded. Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) has declined 5.08% since December 14, 2017 and is downtrending. It has underperformed by 5.08% the S&P500. Some Historical CNSL News: 03/05/2018 – Consolidated Comm Hldgs 1Q EBITDA $135.1M; 03/05/2018 – Consolidated Comm Hldgs 1Q Loss $11.3M; 03/04/2018 – MAGLAN CAPITAL CALLS ON CNSL TO REPURCHASE BONDS TO RETIRE DEBT; 06/03/2018 Kansas CC: Audit of Consolidated Communications Enterprise Services, Inc. by KUSF Administrator; 26/04/2018 – Factors of Influence in 2018, Key Indicators and Opportunity within Compass Minerals International, Consolidated Communications; 03/05/2018 – Consolidated Comm Hldgs 1Q Loss/Shr 16c; 03/04/2018 – MAGLAN CAPITAL LP – URGE CONSOLIDATED COMMUNICATIONS HOLDINGS, TO AUTHORIZE & COMMENCE PROGRAM TO REPURCHASE CO BONDS ON OPEN MARKET; 23/04/2018 – Consolidated Communications Launches DDoS Mitigation Solution; 03/05/2018 – Consolidated Comm Hldgs 1Q Adj Loss/Shr 7c; 03/05/2018 – Consolidated Comm Hldgs 1Q Rev $356M

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Streetinsider.com which released: “Wall Street drops on global growth fears; J&J tumbles on Reuters report – StreetInsider.com” on December 14, 2018, also Seekingalpha.com with their article: “Is Johnson & Johnson A Buy Here? – Seeking Alpha” published on November 19, 2018, Seekingalpha.com published: “J&J’s Tremfya beats Novartis’ Cosentyx in late-stage psoriasis study; shares up 1% premarket – Seeking Alpha” on December 12, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Investorplace.com and their article: “5 Pharma Stocks That Could Cure Ailing Portfolios in 2019 – Investorplace.com” published on December 12, 2018 as well as Seekingalpha.com‘s news article titled: “Johnson & Johnson (JNJ) Management Presents at Citi’s 2018 Global Healthcare Conference (Transcript) – Seeking Alpha” with publication date: December 05, 2018.

Since August 27, 2018, it had 0 insider purchases, and 7 insider sales for $79.41 million activity. Fasolo Peter also sold $24.41 million worth of Johnson & Johnson (NYSE:JNJ) shares. 8,441 shares valued at $1.23 million were sold by Kapusta Ronald A on Thursday, November 8. Duato Joaquin sold $5.77M worth of Johnson & Johnson (NYSE:JNJ) on Wednesday, November 7. Gorsky Alex sold $38.60 million worth of stock or 264,465 shares.

Among 25 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 4 Sell and 9 Hold. Therefore 48% are positive. Johnson & Johnson had 108 analyst reports since August 7, 2015 according to SRatingsIntel. Deutsche Bank maintained the stock with “Buy” rating in Wednesday, April 18 report. Wells Fargo upgraded Johnson & Johnson (NYSE:JNJ) on Monday, October 9 to “Buy” rating. The stock has “Equal-Weight” rating by Morgan Stanley on Thursday, October 11. The stock has “Hold” rating by Jefferies on Friday, July 14. The stock of Johnson & Johnson (NYSE:JNJ) earned “Neutral” rating by Goldman Sachs on Thursday, July 12. As per Tuesday, June 13, the company rating was maintained by Cowen & Co. The stock of Johnson & Johnson (NYSE:JNJ) has “Hold” rating given on Monday, October 2 by Piper Jaffray. Jefferies maintained it with “Hold” rating and $145.0 target in Tuesday, August 15 report. The rating was upgraded by Goldman Sachs on Monday, March 14 to “Neutral”. The rating was maintained by Jefferies on Friday, June 16 with “Hold”.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on January, 22. They expect $1.95 earnings per share, up 12.07% or $0.21 from last year’s $1.74 per share. JNJ’s profit will be $5.23B for 17.17 P/E if the $1.95 EPS becomes a reality. After $2.05 actual earnings per share reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -4.88% negative EPS growth.

Investors sentiment increased to 1.05 in 2018 Q3. Its up 0.08, from 0.97 in 2018Q2. It increased, as 43 investors sold JNJ shares while 748 reduced holdings. 115 funds opened positions while 719 raised stakes. 1.70 billion shares or 7.91% less from 1.84 billion shares in 2018Q2 were reported. Merian Glob Investors (Uk) Limited, United Kingdom-based fund reported 184,320 shares. Boston Advsr Limited Co stated it has 0.46% of its portfolio in Johnson & Johnson (NYSE:JNJ). Boltwood Cap Mngmt holds 11,950 shares or 0.98% of its portfolio. Rnc Capital Management Limited Com invested in 2.09% or 229,488 shares. Boston Family Office Ltd holds 2.16% or 148,024 shares in its portfolio. Frontier Inv reported 2.49% of its portfolio in Johnson & Johnson (NYSE:JNJ). Vaughan Nelson Invest Management LP holds 0.42% or 259,800 shares. Greenleaf Trust reported 0.16% of its portfolio in Johnson & Johnson (NYSE:JNJ). Alphamark Advsrs Llc owns 6,634 shares. Lifeplan Grp Inc stated it has 0.09% of its portfolio in Johnson & Johnson (NYSE:JNJ). British Columbia Inv has 997,072 shares for 1.46% of their portfolio. Td Cap Mngmt Ltd Liability Corp invested in 150 shares. Point72 Asset Management Ltd Partnership owns 575,937 shares. Moreover, Edgar Lomax Va has 1.25% invested in Johnson & Johnson (NYSE:JNJ) for 134,279 shares. Strategic Advsr Ltd Limited Liability Company owns 56,780 shares or 2.87% of their US portfolio.

Analysts await Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) to report earnings on March, 7. They expect $-0.11 EPS, down 175.00% or $0.07 from last year’s $-0.04 per share. After $-0.11 actual EPS reported by Consolidated Communications Holdings, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Among 8 analysts covering Consolidated Communications Holdings (NASDAQ:CNSL), 2 have Buy rating, 2 Sell and 4 Hold. Therefore 25% are positive. Consolidated Communications Holdings had 17 analyst reports since September 10, 2015 according to SRatingsIntel. The stock of Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) has “Underperform” rating given on Friday, August 5 by Raymond James. As per Tuesday, January 2, the company rating was upgraded by Drexel Hamilton. Citigroup maintained Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) rating on Friday, August 5. Citigroup has “Sell” rating and $19 target. Jefferies maintained Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) on Friday, May 13 with “Hold” rating. The firm has “Hold” rating given on Wednesday, October 18 by Cowen & Co. Citigroup upgraded Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) on Wednesday, June 7 to “Neutral” rating. As per Thursday, October 20, the company rating was downgraded by Stephens. Raymond James upgraded the stock to “Outperform” rating in Friday, March 10 report. The stock has “Hold” rating by Drexel Hamilton on Monday, June 27. The company was upgraded on Tuesday, December 6 by Raymond James.

Sirios Capital Management L P, which manages about $2.06 billion and $1.94B US Long portfolio, upped its stake in Imperva Inc (NYSE:IMPV) by 162,831 shares to 326,722 shares, valued at $15.18 million in 2018Q3, according to the filing. It also increased its holding in Old Dominion Fght Lines Inc (NASDAQ:ODFL) by 89,293 shares in the quarter, for a total of 256,871 shares, and has risen its stake in Abbott Labs (NYSE:ABT).

More notable recent Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) news were published by: Globenewswire.com which released: “Consolidated Communications Expands its Advanced Unified Communications Offering – GlobeNewswire” on October 08, 2018, also Globenewswire.com with their article: “Consolidated Communications Launches New Data and Voice Solutions for Small and Medium Businesses – GlobeNewswire” published on April 05, 2018, Globenewswire.com published: “Consolidated Communications to Release First-Quarter 2018 Earnings on May 3 – GlobeNewswire” on April 16, 2018. More interesting news about Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) were released by: Globenewswire.com and their article: “Consolidated Communications Completes FairPoint Acquisition Nasdaq:CNSL – GlobeNewswire” published on July 03, 2017 as well as Globenewswire.com‘s news article titled: “Consolidated Communications Launches Cloud Peer Connect Nasdaq:CNSL – GlobeNewswire” with publication date: June 13, 2018.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.